Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001209191-21-023868

Director bought 359,375 shares at $16.00 ($5,750,000)

  • Director acquired 13,002,760 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Thompson Peter A. · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-30 Conversion : show line 1 in the form +12,730,036 13,046,956 I
2021-03-30 Conversion : show line 2 in the form +272,724 272,724 I
2021-03-30 Purchase : show line 3 in the form +46,875 $16.00 $750,000 319,599 I
2021-03-30 Purchase : show line 4 in the form +312,500 $16.00 $5,000,000 13,359,456 I
Open-market purchases · 359,375 sh · avg $16.00 · $5,750,000

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2021-03-30 Conversion : show line 5 in the form Series A Preferred Stock −8,187,100 0 I
2021-03-30 Conversion : show line 6 in the form Series B-1 Preferred Stock −1,572,960 0 I
2021-03-30 Conversion : show line 7 in the form Series B-2 Preferred Stock −1,301,626 0 I
2021-03-30 Conversion : show line 8 in the form Series C Preferred Stock −1,668,350 0 I
2021-03-30 Conversion : show line 9 in the form Series C Preferred Stock −272,724 0 I
Loading xslF345X03/doc4.xml…